Literature DB >> 19465464

Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance.

Amanda I Adler1, Elizabeth J Shaw, Tim Stokes, Francis Ruiz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465464     DOI: 10.1136/bmj.b1668

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  16 in total

1.  Metformin in the diabetic brain: friend or foe?

Authors:  Paula I Moreira
Journal:  Ann Transl Med       Date:  2014-06

2.  Baicalin and its aglycone: a novel approach for treatment of metabolic disorders.

Authors:  Penghua Fang; Mei Yu; Mingyi Shi; Ping Bo; Xuewen Gu; Zhenwen Zhang
Journal:  Pharmacol Rep       Date:  2020-01-08       Impact factor: 3.024

Review 3.  Cellular and molecular mechanisms of metformin: an overview.

Authors:  Benoit Viollet; Bruno Guigas; Nieves Sanz Garcia; Jocelyne Leclerc; Marc Foretz; Fabrizio Andreelli
Journal:  Clin Sci (Lond)       Date:  2012-03       Impact factor: 6.124

4.  Are sulfonylureas less desirable than DPP-4 inhibitors as add-on to metformin in the treatment of type 2 diabetes?

Authors:  Bo Ahrén
Journal:  Curr Diab Rep       Date:  2011-04       Impact factor: 4.810

Review 5.  Metformin and metabolic diseases: a focus on hepatic aspects.

Authors:  Juan Zheng; Shih-Lung Woo; Xiang Hu; Rachel Botchlett; Lulu Chen; Yuqing Huo; Chaodong Wu
Journal:  Front Med       Date:  2015-02-12       Impact factor: 4.592

6.  Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters.

Authors:  Laurence Slama; Frank J Palella; Alison G Abraham; Xiuhong Li; Corinne Vigouroux; Gilles Pialoux; Lawrence Kingsley; Jordan E Lake; Todd T Brown
Journal:  J Antimicrob Chemother       Date:  2014-08-04       Impact factor: 5.790

7.  Rhinorrhea, cough and fatigue in patients taking sitagliptin.

Authors:  James N Baraniuk; Mary J Jamieson
Journal:  Allergy Asthma Clin Immunol       Date:  2010-05-12       Impact factor: 3.406

Review 8.  Diabetes and cardiovascular disease: focus on glucagon-like peptide-1 based therapies.

Authors:  Paul Stranges; Ujjaini Khanderia
Journal:  Ther Adv Drug Saf       Date:  2012-08

9.  AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.

Authors:  Stephen L Pinkosky; Sergey Filippov; Rai Ajit K Srivastava; Jeffrey C Hanselman; Cheryl D Bradshaw; Timothy R Hurley; Clay T Cramer; Mark A Spahr; Ashley F Brant; Jacob L Houghton; Chris Baker; Mark Naples; Khosrow Adeli; Roger S Newton
Journal:  J Lipid Res       Date:  2012-11-01       Impact factor: 5.922

10.  The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study.

Authors:  Sanjoy K Paul; Kerenaftali Klein; David Maggs; Jennie H Best
Journal:  Cardiovasc Diabetol       Date:  2015-01-24       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.